C4 Therapeutics, Inc. (CCCC)
3.10
+0.15
(+5.08%)
USD |
NASDAQ |
Nov 06, 16:00
3.09
-0.01
(-0.32%)
After-Hours: 20:00
C4 Therapeutics Market Cap : 381.01M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 381.01M |
| November 05, 2026 | 362.57M |
| November 04, 2026 | 383.47M |
| November 03, 2026 | 394.53M |
| November 02, 2026 | 394.53M |
| October 30, 2026 | 414.19M |
| October 29, 2026 | 405.59M |
| October 28, 2026 | 417.27M |
| October 27, 2026 | 394.53M |
| October 26, 2026 | 366.26M |
| October 23, 2026 | 376.09M |
| October 22, 2026 | 390.84M |
| October 21, 2026 | 389.61M |
| October 20, 2026 | 388.38M |
| October 19, 2026 | 355.20M |
| October 16, 2026 | 339.83M |
| October 15, 2026 | 341.68M |
| October 14, 2026 | 320.78M |
| October 13, 2026 | 341.68M |
| October 12, 2026 | 376.09M |
| October 09, 2026 | 388.38M |
| October 08, 2026 | 350.28M |
| October 07, 2026 | 346.59M |
| October 06, 2026 | 353.97M |
| October 05, 2026 | 367.49M |
| Date | Value |
|---|---|
| October 02, 2026 | 362.57M |
| October 01, 2026 | 385.92M |
| September 30, 2026 | 409.28M |
| September 29, 2026 | 384.70M |
| September 28, 2026 | 382.85M |
| September 25, 2026 | 366.26M |
| September 24, 2026 | 372.40M |
| September 23, 2026 | 378.55M |
| September 22, 2026 | 406.82M |
| September 21, 2026 | 405.59M |
| September 18, 2026 | 416.65M |
| September 17, 2026 | 419.72M |
| September 16, 2026 | 424.02M |
| September 15, 2026 | 421.57M |
| September 14, 2026 | 421.57M |
| September 11, 2026 | 431.40M |
| September 10, 2026 | 417.88M |
| September 09, 2026 | 422.80M |
| September 08, 2026 | 436.32M |
| September 04, 2026 | 462.13M |
| September 03, 2026 | 459.67M |
| September 02, 2026 | 465.81M |
| September 01, 2026 | 475.65M |
| August 31, 2026 | 455.98M |
| August 28, 2026 | 473.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.589B |
| Kymera Therapeutics, Inc. | 11.24B |
| NKGen Biotech, Inc. | 0.5644M |
| Arrowhead Pharmaceuticals, Inc. | 8.208B |
| Oncolytics Biotech, Inc. | 54.77M |
Market Cap Related Metrics
| PS Ratio | 12.24 |
| Price to Book Value | 1.784 |
| Price | 3.10 |
| Earnings Yield | -23.10% |